Medicare Part D drugs starting with V
87 drugs start with V; 37 of them are on at least 90% of 2026 Part D formularies. Part D spending was highest for Vyndamax in 2024: $2.8 billion, what plans and patients paid at the pharmacy before rebates.
Which drugs start with V?
| Drug | Plans covering | Usual tier | Medicare spending, 2024 |
|---|---|---|---|
| Vabomere (meropenem / vaborbactam) | 0.7% | Tier 4 | $1 million |
| Vabrinty (leuprolide acetate) | 2.8% | Tier 5 | no 2024 match |
| Vagifem (estradiol) | under 0.1% | Tier 1 | $3 million |
| Valacyclovir | 100% | Tier 2 | $107 million |
| Valchlor (mechlorethamine) | 100% | Tier 5 | $14 million |
| Valcyte (valganciclovir) | under 0.1% | Tier 1 | $85 thousand |
| Valganciclovir | 100% | Tier 3 | $28 million |
| Valproic acid | 100% | Tier 2 | $16 million |
| Valsartan | 100% | Tier 1 | $128 million |
| Valtoco (diazepam) | 100% | Tier 4 | $24 million |
| Valtrex (valacyclovir) | under 0.1% | Tier 1 | $4 million |
| Valtya (ethinyl estradiol / ethynodiol diacetate) | 95.1% | Tier 2 | no 2024 match |
| Vancocin (vancomycin) | 0.1% | Tier 4 | no 2024 match |
| Vancomycin | 100% | Tier 4 | $52 million |
| Vandazole (metronidazole) | 13.1% | Tier 4 | $215 thousand |
| Vanflyta (quizartinib) | 100% | Tier 5 | $8 million |
| Vanrafia (atrasentan) | 1% | Tier 5 | no 2024 match |
| Vaqta (hepatitis A vaccine) | 100% | Tier 1 | $1 million |
| Varenicline | 100% | Tier 4 | $133 million |
| Varivax (chickenpox vaccine) | 100% | Tier 1 | $554 thousand |
| Varubi (rolapitant) | 4.7% | Tier 3 | $533 thousand |
| Vascepa (icosapent ethyl) | 78.7% | Tier 3 | $724 million |
| Vaseretic (enalapril maleate / hydrochlorothiazide) | under 0.1% | Tier 1 | $76 thousand |
| Vasotec (enalapril maleate) | under 0.1% | Tier 1 | $3 million |
| Vaxchora (cholera vaccine) | 100% | Tier 1 | $12 thousand |
| Vecamyl (mecamylamine hydrochloride) | 0.4% | Tier 5 | no 2024 match |
| Velivet (desogestrel / ethinyl estradiol) | 91.3% | Tier 2 | $33 thousand |
| Velphoro (sucroferric oxyhydroxide) | 5.3% | Tier 5 | $438 million |
| Velsipity (etrasimod) | 28.4% | Tier 5 | $2 million |
| Veltassa (patiromer) | 34% | Tier 3 | $175 million |
| Vemlidy (tenofovir alafenamide) | 57.2% | Tier 5 | $199 million |
| Venclexta (venetoclax) | 100% | Tier 3 | $942 million |
| Venlafaxine | 100% | Tier 2 | $136 million |
| Ventolin (albuterol) | 70% | Tier 3 | $153 million |
| Venxxiva (tiopronin) | 3.2% | Tier 5 | no 2024 match |
| Veozah (fezolinetant) | 44% | Tier 4 | $38 million |
| Verapamil hydrochloride | 100% | Tier 1 | $85 million |
| Veregen (sinecatechins) | 1% | Tier 4 | $223 thousand |
| Verkazia (cyclosporine) | 3% | Tier 5 | $260 thousand |
| Verquvo (vericiguat) | 100% | Tier 3 | $50 million |
Show the other 47 drugs
Source: CMS Part D formulary file, 2026 second quarter; CMS Medicare Part D Spending by Drug, 2024.
What else should you check?
- Every drug, by letterAnd the 20 that cost Medicare most
- Stand-alone drug plans for 2027Premiums and deductibles
- Part D in 2027What changes for drug plans